Earnings History Data for 4D Molecular Therapeutics, Inc. (FDMT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics Inc. is a clinical-stage gene therapy company which develops product candidates using its targeted and evolved adeno-associated viruses vectors. It offers a portfolio of gene therapy product candidates focusing on the ophthalmology, cardiology and pulmonology therapeutic areas. 4D Molecular Therapeutics Inc. is based in Emeryville, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-11-2024	AH		FDMT	4D Molecular Therapeutics	419.00	-0.79	-0.67	0.00	4D Molecular Therapeutics GAAP EPS of -$0.79 misses by $0.10 [11/13/2024 4:40 PM]	8.03	0.32 (4.09%)	7.71	0.0 (0.00%)	7.32 - 36.25	961,992	660,000	11,546
4D Molecular Therapeutics GAAP EPS of -$0.79 misses by $0.10 [11/13/2024 4:40 PM]
08-08-2024	PM		FDMT	4D Molecular Therapeutics	801.00	-0.63	-0.72	0.00	4D Molecular Therapeutics GAAP EPS of -$0.63 beats by $0.06, revenue of $0.01M misses by $0.68M [8/9/2024 3:22 AM]	14.77	0.04 (0.27%)	14.97	0.24 (1.63%)	9.44 - 36.25	366,965	630,000	18,417
4D Molecular Therapeutics GAAP EPS of -$0.63 beats by $0.06, revenue of $0.01M misses by $0.68M [8/9/2024 3:22 AM] 4D Molecular Therapeutics Fabry candidate clinical hold lifted [8/9/2024 2:46 PM]
29-02-2024	AH		FDMT	4D Molecular Therapeutics	1,279	-0.77	-0.68	0.00	4D Molecular Therapeutics GAAP EPS of -$2.58 [2/29/2024 6:06 PM]	29.42	1.40 (5.00%)	28.80	0.78 (2.78%)	9.44 - 35.61	515,609	730,000	408
4D Molecular Therapeutics GAAP EPS of -$2.58 [2/29/2024 6:06 PM]
09-11-2023	AH		FDMT	4D Molecular Therapeutics	500.00	-0.24	-0.67	0.00	4D Molecular Therapeutics GAAP EPS of -$0.24 beats by $0.37, revenue of $20.2M beats by $10.98M [11/9/2023 5:50 PM]	11.04	0.54 (5.14%)	10.75	0.25 (2.38%)	8.57 - 26.49	331,856	320,000	1,623
4D Molecular Therapeutics GAAP EPS of -$0.24 beats by $0.37, revenue of $20.2M beats by $10.98M [11/9/2023 5:50 PM]
09-08-2023	AH		FDMT	4D Molecular Therapeutics	544.00	-0.77	-0.77	0.00	4D Molecular Therapeutics GAAP EPS of -$0.77 misses by $0.01, revenue of $0.24M misses by $0.78M [8/9/2023 6:01 PM]	16.55	-0.48 (-2.85%)	17.05	0.01 (0.06%)	6.58 - 26.49	193,239	270,000	25,093
4D Molecular Therapeutics GAAP EPS of -$0.77 misses by $0.01, revenue of $0.24M misses by $0.78M [8/9/2023 6:01 PM]
10-05-2023	AH	4:05 PM ET (May 10)	FDMT	4D Molecular Therapeutics	532.00	-0.88	-0.88	0.00	4D Molecular Therapeutics GAAP EPS of -$0.88, revenue of $0.3M [5/10/2023 5:27 PM]	16.81	-0.84 (-4.76%)	17.65	0.0 (0.00%)	5.32 - 26.49	540,802	980,000	327,753
4D Molecular Therapeutics GAAP EPS of -$0.88, revenue of $0.3M [5/10/2023 5:27 PM]
15-03-2023	AH	4:05 PM ET (Mar 15)	FDMT	4D Molecular Therapeutics	567.00	-0.84	-0.75	0.00	4D Molecular Therapeutics GAAP EPS of -$3.32 misses by $0.12, revenue of $3.13M misses by $1.28M [3/15/2023 4:51 PM]	18.41	1.04 (6.02%)	0.0	0.0 (0.00%)	5.32 - 26.49	420,382	400,000	0
4D Molecular Therapeutics GAAP EPS of -$3.32 misses by $0.12, revenue of $3.13M misses by $1.28M [3/15/2023 4:51 PM]
28-03-2022	AH		FDMT	4D Molecular Therapeutics	531.00	-0.85	-0.82	0.00	4D Molecular Therapeutics GAAP EPS of -$2.57, revenue of $18.03M [3/28/2022 4:38 PM]	16.19	0.78 (5.06%)	15.41	0.0 (0.00%)	12.84 - 44.03	183,869	160,000	731
4D Molecular Therapeutics GAAP EPS of -$2.57, revenue of $18.03M [3/28/2022 4:38 PM] 4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights [Mar-28-22 04:02PM]
10-11-2021	AH		FDMT	4D Molecular Therapeutics	673.00	-0.82	-0.83	0.00	4D Molecular Therapeutics EPS beats by $0.01 [11/10/2021 4:41 PM]	24.78	0.06 (0.23%)	24.72	0.0 (0.00%)	21.40 - 55.11	162,661	500,000	1,301
4D Molecular Therapeutics EPS beats by $0.01 [11/10/2021 4:41 PM] 4D Molecular Therapeutics Reports Financial Results for the Third Quarter of 2021 and Provides Operational Highlights [Nov-10-21 04:01PM]